Newsroom - Alvotech - Better Access Better Lives

Skip Navigation

Alvotech

Latest news

12 November 2025

Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update

10 November 2025

UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)

06 November 2025

Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA

Media Contact

Benedikt Stefansson

Director of Investor Relations and Global Communications

Phone +354 422 4500

Connect on Linkedin

Media Gallery

Download center for company logos and images

Alvotech 2022. All rights reserved.